Skip to content
ACB Aurora Cannabis Inc NASDAQ
1.00 USD -4.76% -0.05
OPEN 1.06
DAY RANGE 1.06 - 0.98
52 WEEK RANGE 4.90 - 0.82
Interactive Brokers Logotype

Buy ACB stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 333.2M
Enterprise value 251.9M
Trailing pe -0.12515644555695
Forward pe -5.924706
Peg ratio -5.924706
Price to sales ttm 1.583
Price to book mrq 0.5438445
Enterprise to revenue 1.605
Enterprise to ebitda -2.048


Fiscal year ends 2022-06-30
Most recent quarter 2022-06-30
Profit margin 0.095893629229372
Operating margin -1.0849199
Return on assets ttm -0.07653
Return on equity ttm -1.34224
Income statement
Revenue ttm 157M
Revenue per share ttm 0.875
Quarterly revenue growth -0.18
Gross profit ttm 15.8M
Ebitda -122977193
Net income to common ttm -1310627155
Diluted eps ttm -4.702
Balance sheet
Total cash mrq 275.7M
Total cash per share mrq 1.14
Total debt mrq 242.8M
Total debt to equity mrq 54.763
Current ratio mrq 4.067
Book value per share mrq 1.852
Cash flow
Operating cash flow ttm -88231123
Levered free cash flow ttm -81044689

Stock statistics

Shares outstanding 324.3M
Float shares 307.5M
Avg 10 volume 8.2M
Avg 30 volume 7.5M
Shares short 30.9M
Short ratio 3.59
Percent held by insiders 0.00071999995
Percent held by institutions 0.20931

Stock price summary

Fifty two week low 0.821
Fifty two week high 4.9
Fifty two week change -317
Beta 2.989194
Day 50 ma 1.04486
Day 200 ma 1.504015

Dividends and splits

Dividend date 2020-05-11
Last split factor 1-for-12 split
Last split date 2020-05-11

Aurora Cannabis Inc. (ACB) Company Profile

Aurora Cannabis Inc. is a Canadian licensed cannabis producer with headquarters in Edmonton. Aurora was founded on December 21, 2006, by Terry Booth, Steve Dobler, Dale Lesack, and Chris Mayerson. The company went public on October 23, 2018, and it trades on the New York Stock Exchange (NYSE) under the ticker ACB.

Through its subsidiaries, Aurora Cannabis engages in the production and distribution of medical cannabis products worldwide. The company structure is vertically integrated and horizontally diversified across several segments of the cannabis value chain.

The chain includes facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. Furthermore, Aurora produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

It also sells vaporizers; consumable vaporizer accessories. The company engages in developing medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and the operation of CanvasRX.

Aurora Cannabis main competitors

  • Aphria
  • The Cronos Group
  • CannTrust Holdings
  • OrganiGram Holdings

Key Aurora Cannabis milestone

In January 2018, Aurora became the first private company to earn the rights to supply the Italian market through its German subsidiary Pedanios. According to the company, the first tender consisted of three lots of different cannabinoid profiles amounting to 100 kg.

In November 2019, Aurora opened an 11,000 square foot flagship retail center in West Edmonton Mall. The space is the largest retail outlet in Canada.

In March 2018, Aurora announced the completion of their acquisition of Cannimed, with both parties agreeing to the transaction based on friendly terms. With the agreement, Aurora’s total patient count to 42,000 registered cannabis patients in Canada.

Aurora Cannabis Frequently Asked Questions

Does Aurora Cannabis pay dividends?

Aurora Cannabis does not pay traditional dividends to investors.

Has Aurora split its stock?

Since going public, Aurora has split its stock once. 

In which countries does Aurora cannabis operate?

Aurora Cannabis had eight licensed production facilities, five sales licenses, and operations in 25 countries.